NEKTAR THERAPEUTICS Quarterly Goodwill in USD from Q4 2010 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.
Summary
Nektar Therapeutics quarterly Goodwill history and growth rate from Q4 2010 to Q4 2023.
  • Nektar Therapeutics Goodwill for the quarter ending December 31, 2023 was $0.000, a 100% decline year-over-year.
Goodwill, Quarterly (USD)
Goodwill, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $0 -$76.5M -100% Dec 31, 2023 10-K 2024-03-05
Q3 2023 $0 -$76.5M -100% Sep 30, 2023 10-Q 2023-11-08
Q2 2023 $0 -$76.5M -100% Jun 30, 2023 10-Q 2023-08-09
Q1 2023 $0 -$76.5M -100% Mar 31, 2023 10-Q 2023-05-10
Q4 2022 $76.5M $0 0% Dec 31, 2022 10-K 2024-03-05
Q3 2022 $76.5M $0 0% Sep 30, 2022 10-Q 2022-11-04
Q2 2022 $76.5M $0 0% Jun 30, 2022 10-Q 2022-08-05
Q1 2022 $76.5M $0 0% Mar 31, 2022 10-Q 2022-05-06
Q4 2021 $76.5M $0 0% Dec 31, 2021 10-K 2023-02-28
Q3 2021 $76.5M $0 0% Sep 30, 2021 10-Q 2021-11-05
Q2 2021 $76.5M $0 0% Jun 30, 2021 10-Q 2021-08-06
Q1 2021 $76.5M $0 0% Mar 31, 2021 10-Q 2021-05-07
Q4 2020 $76.5M $0 0% Dec 31, 2020 10-K 2022-03-01
Q3 2020 $76.5M $0 0% Sep 30, 2020 10-Q 2020-11-06
Q2 2020 $76.5M $0 0% Jun 30, 2020 10-Q 2020-08-07
Q1 2020 $76.5M $0 0% Mar 31, 2020 10-Q 2020-05-08
Q4 2019 $76.5M $0 0% Dec 31, 2019 10-K 2021-02-26
Q3 2019 $76.5M $0 0% Sep 30, 2019 10-Q 2019-11-07
Q2 2019 $76.5M $0 0% Jun 30, 2019 10-Q 2019-08-09
Q1 2019 $76.5M $0 0% Mar 31, 2019 10-Q 2019-05-09
Q4 2018 $76.5M $0 0% Dec 31, 2018 10-K 2020-02-28
Q3 2018 $76.5M $0 0% Sep 30, 2018 10-Q 2018-11-08
Q2 2018 $76.5M $0 0% Jun 30, 2018 10-Q 2018-08-09
Q1 2018 $76.5M $0 0% Mar 31, 2018 10-Q 2018-05-10
Q4 2017 $76.5M $0 0% Dec 31, 2017 10-K 2019-03-01
Q3 2017 $76.5M $0 0% Sep 30, 2017 10-Q 2017-11-08
Q2 2017 $76.5M $0 0% Jun 30, 2017 10-Q 2017-08-09
Q1 2017 $76.5M $0 0% Mar 31, 2017 10-Q 2017-05-10
Q4 2016 $76.5M $0 0% Dec 31, 2016 10-K 2018-03-01
Q3 2016 $76.5M $0 0% Sep 30, 2016 10-Q 2016-11-04
Q2 2016 $76.5M $0 0% Jun 30, 2016 10-Q 2016-08-04
Q1 2016 $76.5M $0 0% Mar 31, 2016 10-Q 2016-05-04
Q4 2015 $76.5M $0 0% Dec 31, 2015 10-K 2017-03-01
Q3 2015 $76.5M $0 0% Sep 30, 2015 10-Q 2015-11-06
Q2 2015 $76.5M $0 0% Jun 30, 2015 10-Q 2015-08-06
Q1 2015 $76.5M $0 0% Mar 31, 2015 10-Q 2015-05-01
Q4 2014 $76.5M $0 0% Dec 31, 2014 10-K 2016-03-01
Q3 2014 $76.5M $0 0% Sep 30, 2014 10-Q 2014-11-07
Q2 2014 $76.5M $0 0% Jun 30, 2014 10-Q 2014-08-01
Q1 2014 $76.5M $0 0% Mar 31, 2014 10-Q 2014-05-08
Q4 2013 $76.5M $0 0% Dec 31, 2013 10-K 2015-02-26
Q3 2013 $76.5M $0 0% Sep 30, 2013 10-Q 2013-11-07
Q2 2013 $76.5M $0 0% Jun 30, 2013 10-Q 2013-08-09
Q1 2013 $76.5M $0 0% Mar 31, 2013 10-Q 2013-05-09
Q4 2012 $76.5M $0 0% Dec 31, 2012 10-K 2014-02-27
Q3 2012 $76.5M $0 0% Sep 30, 2012 10-Q 2012-11-09
Q2 2012 $76.5M $0 0% Jun 30, 2012 10-Q 2012-08-09
Q1 2012 $76.5M $0 0% Mar 31, 2012 10-Q 2012-05-04
Q4 2011 $76.5M $0 0% Dec 31, 2011 10-K 2013-03-01
Q3 2011 $76.5M Sep 30, 2011 10-Q 2011-11-04
Q2 2011 $76.5M Jun 30, 2011 10-Q 2011-08-05
Q1 2011 $76.5M Mar 31, 2011 10-Q 2011-04-29
Q4 2010 $76.5M Dec 31, 2010 10-K 2012-02-29
* An asterisk sign (*) next to the value indicates that the value is likely invalid.